Thanks for alerting us arou011.
A good interpretation of the results.
I particularly like their year on year valuations... $5 wouldn't hurt ;)
One point I'm not so sure about is their assumption of first sales in Australia occurring in 2014.
This would precede Phase 3 primary endpoints, so do they believe CVac will be fast tracked by the TGA?
Or are they presuming revenue from compassionate use?
- Forums
- ASX - By Stock
- interim data from can-003 clinical trial
Thanks for alerting us arou011.A good interpretation of the...
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
31.5¢ |
Change
-0.015(4.55%) |
Mkt cap ! $458.1M |
Open | High | Low | Value | Volume |
32.5¢ | 32.5¢ | 31.0¢ | $1.029M | 3.271M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 51296 | 31.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.0¢ | 30000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 51296 | 0.315 |
8 | 419782 | 0.310 |
5 | 57878 | 0.305 |
10 | 133796 | 0.300 |
4 | 48639 | 0.295 |
Price($) | Vol. | No. |
---|---|---|
0.320 | 30000 | 1 |
0.325 | 30000 | 1 |
0.330 | 57226 | 4 |
0.335 | 77230 | 3 |
0.340 | 81685 | 3 |
Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |